Patents Assigned to Sirna Theraputics, Inc.
  • siRNA treatment of diseases or conditions related to levels of IKK-gamma
    Patent number: 7022828
    Abstract: The present invention relates to nucleic acid molecules, including antisense and enzymatic nucleic acid molecules, such as hammerhead ribozymes, DNAzymes, allozymes, aptamers, decoys and siRNA (RNAi), which modulate the expression or function of IKK genes, such as IKK-gamma, IKK-alpha, or IKK-beta, and PKR genes.
    Type: Grant
    Filed: May 28, 2002
    Date of Patent: April 4, 2006
    Assignee: Sirna Theraputics, Inc.
    Inventor: James A. McSwiggen
  • Polymearase III-based expression of therapeutic RNAs
    Publication number: 20050176038
    Abstract: A transcribed non-naturally occurring RNA molecule comprising a desired 10 RNA molecule, wherein the 3+ region of the RNA is able to base-pair with at least 8 bases at the 5? terminus of the same RNA molecule.
    Type: Application
    Filed: December 23, 2004
    Publication date: August 11, 2005
    Applicant: Sirna Theraputics, Inc.
    Inventor: James Thompson